Quick Takeaways
- Rubric Capital Management LP filed SCHEDULE 13G/A for Adaptive Biotechnologies Corporation Common stock, par value $0.0001 per share (ADPT).
- Disclosed ownership: 4.1%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"Rubric Capital Management LP disclosed 4.1% ownership in Adaptive Biotechnologies Corporation Common stock, par value $0.0001 per share (ADPT) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP | 4.1% | 6,256,847 | 0 | 6,256,847 | /s/ Michael Nachmani | Michael Nachmani / Chief Operating Officer | |
| David Rosen | 4.1% | 6,256,847 | 0 | 6,256,847 | /s/ David Rosen | David Rosen, Individually |